Statin Equivalence
This chart provides a reference for approximate equivalent doses of statins based on their expected LDL-C reduction. Doses are not necessarily interchangeable and clinical judgment is required.
| Lipophilic | Hydrophilic |
LDL-C Reduction |
|||||
|---|---|---|---|---|---|---|---|
| Fluvastatin | Pitavastatin | Lovastatin | Simvastatin | Atorvastatin | Rosuvastatin | Pravastatin | |
| 40 mg | 1 mg | 20 mg | 10 mg | 20 mg | 30% | ||
| 80 mg | 2 mg | 40 mg | 20 mg | 10 mg | 40 mg | 38% | |
| 4 mg | 80 mg | 40 mg | 20 mg | 5 mg | 80 mg | 41% | |
| 40 mg | 10 mg | 47% | |||||
| 80 mg | 20 mg | 55% | |||||
| 40 mg | 63% | ||||||
Low-Intensity and High-Intensity2
Statin Metabolization Pathways
| Statin | CYP2C9 | CYP3A4 | Pgp | OATP1B1 | OATP1B3 |
|---|---|---|---|---|---|
| Atorvastatin | ✔️ | ✔️ | ✔️ | ||
| Fluvastatin | ✔️ | ✔️ | |||
| Lovastatin | ✔️ | ✔️ | |||
| Pravastatin | ✔️ | ✔️ | |||
| Rosuvastatin | ✔️ | ✔️ | ✔️ | ||
| Simvastatin | ✔️ | ✔️ | ✔️ |
Pgp: P-glycoprotein; OATP: organic anion-transporting polypeptide.
References
- FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin)
- Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014;129(25_suppl_2).
- Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or Lipophilic Statins? Front Cardiovasc Med. 2021 May 20;8:687585.